SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PSDV - pSivida Limited
PSDV 1.220+14.0%Mar 29 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenhott who wrote (98)9/9/2009 12:54:21 PM
From: Arthur Radley  Read Replies (1) of 421
 
Ken,
Good analysis.....safety is the key! This stock isn't an investment....tis really a gamble! I've tried to give enough caveats on the potential for this 'investment',and as stated, there is no exit strategy if they announce any bad news with the Phase III data. My concern is the OP issue....they have already announced the high dosage cause problems, so will the low dosage over a longer period of the implant cause the same event? Another minor issue is the fact that they put in every PR that Pfizer holds their stock........but never a word about PFE doing anything with their delivery system.

The good news for me is that I'm near a trigger point to cut my position in half and be net free of cost........then I can let it ride without the concern of faulty Phase III data.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext